[Wang, Zhe; Liu, Yunmei; Zou, Liu; Liu, Juan; Zheng, X; Tang, GT; Tang, Guotao; Zheng, Xing; Deng, Xiangping; Xie, Zhizhong; Lei, Xiaoyong; Xiong, Shujuan; Xiong, Runde; Cao, Xuan] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Inst Pharm & Pharmacol, Hengyang, Peoples R China.

[Chen, Yanming] Mu Dan Jiang You Bo Pharmacert Co Ltd, Mudanjiang, Peoples R China.

[Zheng, X; Tang, GT] U

Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Inst Pharm & Pharmacol, Hengyang, Peoples R China.

antineoplastic agent;benzimidazole derivative;chrysin;compound 10;compound 11;compound 12;compound 13;compound 14;compound 15;compound 16;compound 17;compound 18;compound 19;compound 21;compound 22;compound 23;compound 3;compound 4;compound 5;compound 6;compound 7;compound 8;compound 9;fluorouracil;unclassified drug;antineoplastic agent;benzimidazole derivative;chrysin;flavonoid;animal experiment;animal model;antineoplastic activity;antiproliferative activity;apoptosis;Article;breast cancer;cancer inhibition;cell cycle arrest;cell cycle G0 phase;cell cycle G1 phase;controlled study;dose response;drug design;drug megadose;drug potency;drug screening;drug synthesis;Hep-G2 cell line;IC50;in vitro study;in vivo study;male;MCF-7 cell line;mouse;nonhuman;animal;cell cycle;cell proliferation;chemistry;drug effect;drug screening;human;synthesis;tumor cell line;xenograft;Animals;Antineoplastic Agents;Apoptosis;Benzimidazoles;Cell Cycle;Cell Line, Tumor;Cell Proliferation;Drug Design;Drug Screening Assays, Antitumor;Flavonoids;Heterografts;Humans;Mice

药学与生物科学学院